Effect of Donor Chose on the Outcomes of GVHD Prophylaxis Underwent the Combined Treatment of ATG/PTCy for Haplo-HSCT

Conditions

• High-Risk Acute Myeloid Leukemia
• Relapse And/or Refractory AML

Interventions

• OTHER: None-placebo
• OTHER: non-intervention study
• OTHER: donor selection

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine